Advertisement
Research Article

No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

  • Marlous L. Grijsen equal contributor mail,

    equal contributor Contributed equally to this work with: Marlous L. Grijsen, Radjin Steingrover

    m.l.grijsen@amc.uva.nl

    Affiliation: Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • Radjin Steingrover equal contributor,

    equal contributor Contributed equally to this work with: Marlous L. Grijsen, Radjin Steingrover

    Affiliations: Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health, Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • Ferdinand W. N. M. Wit,

    Affiliation: Department of Global Health, Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • Suzanne Jurriaans,

    Affiliation: Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • Annelies Verbon,

    Affiliation: Department of Medical Microbiology, Maastricht University Medical Center, Maastricht, The Netherlands

    Current address: Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

    X
  • Kees Brinkman,

    Affiliation: Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands

    X
  • Marchina E. van der Ende,

    Affiliation: Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

    X
  • Robin Soetekouw,

    Affiliation: Department of Internal Medicine, Kennemer Gasthuis, Haarlem, The Netherlands

    X
  • Frank de Wolf,

    Affiliation: HIV Monitoring Foundation, Amsterdam, The Netherlands

    X
  • Joep M. A. Lange,

    Affiliation: Department of Global Health, Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • Hanneke Schuitemaker,

    Affiliation: Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • Jan M. Prins,

    Affiliation: Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    X
  • on behalf of the Primo-SHM Study Group
  • Published: March 27, 2012
  • DOI: 10.1371/journal.pmed.1001196

Reader Comments (0)

Post a new comment on this article